Last reviewed · How we verify

NCT02973412: CODEC

Chronotype of Patients With Diabetes and Effect on Glycaemic Control

Recruiting now Last updated 15 February 2024
What this trial tests

trial in Diabetes Mellitus, Type 1 in 3,447 participants. Currently enrolling.

Timeline
7 December 2016
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorUniversity of Leicester
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment3,447
Start date7 December 2016
Primary completion31 December 2027
Estimated completion31 December 2027
Sites1 location across United Kingdom

Conditions studied

Sponsor

University of Leicester

Who can join

Adults 18 to 75, any sex, with Diabetes Mellitus, Type 1 or Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to explore the associations between chronotype and glycaemic control, cardiometabolic health and other lifestyle factors.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Physical behaviors and chronotype in people with type 2 diabetes.
    Henson J, Rowlands AV, Baldry E, Brady EM, et al · · 2020 · cited 32× · PMID 32675292 · DOI 10.1136/bmjdrc-2020-001375
  2. The impact of COVID-19 restrictions on accelerometer-assessed physical activity and sleep in individuals with type 2 diabetes.
    Rowlands AV, Henson JJ, Coull NA, Edwardson CL, et al · · 2021 · cited 25× · PMID 33650112 · DOI 10.1111/dme.14549
  3. Rationale and design of a cross-sectional study to investigate and describe the chronotype of patients with type 2 diabetes and the effect on glycaemic control: the CODEC study.
    Brady EM, Hall AP, Baldry E, Chatterjee S, et al · · 2019 · cited 23× · PMID 31719069 · DOI 10.1136/bmjopen-2018-027773
  4. Age at diagnosis of type 2 diabetes and cardiovascular risk factor profile: A pooled analysis.
    Barker MM, Zaccardi F, Brady EM, Gulsin GS, et al · · 2022 · cited 13× · PMID 35432761 · DOI 10.4239/wjd.v13.i3.260
  5. Self-compassion, sleep quality and psychological well-being in type 2 diabetes: a cross-sectional study.
    Gunn S, Henson J, Robertson N, Maltby J, et al · · 2022 · cited 12× · PMID 36171016 · DOI 10.1136/bmjdrc-2022-002927
  6. Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus.
    Belfield AE, Wilkinson TJ, Henson J, Sargeant JA, et al · · 2024 · cited 9× · PMID 38706394 · DOI 10.1093/ageing/afae090
  7. Accelerometer-Assessed Physical Activity in People with Type 2 Diabetes: Accounting for Sleep when Determining Associations with Markers of Health.
    Rowlands AV, van Hees VT, Dawkins NP, Maylor BD, et al · · 2023 · cited 7× · PMID 37420551 · DOI 10.3390/s23125382
  8. Relative protein intake and associations with markers of physical function in those with type 2 diabetes.
    Henson J, Arsenyadis F, Redman E, Brady EM, et al · · 2022 · cited 6× · PMID 35426174 · DOI 10.1111/dme.14851

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

Other University of Leicester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02973412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing